Felton, 3 December
2019 - In Vitro Diagnostics (IVD) Market size
is likely to reach USD 98.99 billion by 2025 and is anticipated to grow at a
CAGR of 6.6% during the forecast period. In-Vitro diagnostics is an extensive
range of veterinary and medical laboratory tests that are used to analyze
diseases and constantly monitor the clinical status of patients using samples
of blood, cells, or other tissues attained from a patient.
Considering its driving factors, the growing geriatric
population that is very much susceptible to diseases, needs constant diagnostic
tests. Additionally, technological expansions in terms of precision,
compactness, and cost-effectiveness are helping the market to fast-track the
demand for In-Vitro diagnostics industry in the current scenario.
Request a PDF Sample
@ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-market/request-sample
The In Vitro diagnostics (IVD) industry is segmented on the
basis of product & service (Reagents & Kits, Instruments,
Fully-automated Instruments, Semi-automated Instruments, Others, Data
Management Software, Services);
Technology segment comprises (Immunochemistry/Immunoassay
(Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay
(CLIA), Fluorescence Immunoassay (FIA), Colorimetric Immunoassay (CI),
Radioimmunoassays (RIA), Rapid Tests,Western Blot, ELISPOT), Clinical Chemistry
(Basic Metabolic Panel, Electrolyte Panel, Liver Panel, Lipid Profile, Renal
Profile, Thyroid Function Panel, Specialty Chemicals), Molecular Diagnostics
(Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification
Technology (INAAT), Hybridization (In-situ Hybridization & FISH), DNA
Sequencing & NGS, Microarray, Others), Microbiology, Hematology,
Coagulation & Hemostasis, Urinalysis, Others);
End user segmentation for In Vitro Diagnostics market
includes (Laboratories (Large/Reference Laboratories, Medium-sized
Laboratories, Small Laboratories), Hospitals, Academics, Point-Of-Care Testing,
Patient Self-Testing, Others) and by region (North America, Europe, Asia
Pacific, Latin America, Middle East & Africa).
Based on product, reagents & kits dominated the In Vitro
diagnostics industry and held the highest market share as the usage of IVD
testing has increased. Along with this, taking the technology insights into
consideration, clinical chemistry controlled the market by generating higher
revenue.
Geographically, North America is expected to dominate the
IVD market as it holds the largest market share owing to the availability of
government funds, and increase in the usage of molecular diagnostics in cancer
screening and genetic disorders. Followed by this, Asia Pacific is likely to
command the highest growth rate during the estimated time span due to the rise
in the number of hospitals and an increase in healthcare expenditure. In the
near future In-Vitro diagnostics (IVD) industry will continue to come up with
some extraordinary product innovations to attract new consumers and investors,
for them to continue the domination.
Some of the prominent key players outlined in the In-Vitro
diagnostics (IVD) market report are Cepheid, Siemens Healthineers, Qiagen,
bioMerieux SA, Sysmex Corporation, Hologic, Inc. (Gen-Probe), F. Hoffmann-La
Roche Ltd., Becton, Dickinson and Company, Hologic, Inc. (Gen-Probe), Abbott,
Alere and Danaher. All the leading companies are including mergers and
acquisitions, partnerships and joint ventures to enhance the growth of the
market efficiently.
Market Segment:
In Vitro Diagnostics
(IVD) Product Outlook (Revenue, USD Billion, 2014 - 2025)
• Instruments
• Reagents
• Services
In Vitro Diagnostics
(IVD) Technology Outlook (Revenue, USD Billion, 2014 - 2025)
• Immunology
• Hematology
• Clinical
chemistry
• Molecular
Diagnostics
• Coagulation
• Microbiology
• Others
For More Technical
Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-market
No comments:
Post a Comment